Related Experiment Video
Updated: Aug 30, 2026

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay
Published on: March 10, 2015
Humanized knock-in mice expressing chimeric prion protein showed varied susceptibility to different human prions
Yuzuru Taguchi1, Shirou Mohri, James W Ironside
1Department of Neurological Science, Tohoku University Graduate School of Medicine, Sendai, Japan.
Abstract:
Mice to which human prions efficiently transmit in short incubation periods are valuable not only as research tools of human prions but also as reliable diagnostic tools. We recently produced a line of knock-in mouse expressing a unique human-mouse chimeric PrP (Ki-ChM mouse), which has mouse-specific residues practically only at the C-terminal part after posttranslational modification, and here we attempted transmission of various human prions to assess the susceptibility profile of the mouse. Susceptibility varied considerably depending on prions inoculated: highly susceptible to MM1 and MV1 types of sporadic Creutzfeldt-Jakob disease (CJD), developing disease within approximately 150 days, familial CJD with M232R mutation, and dura graft-associated CJD (dCJD) without amyloid plaque; less susceptible to MM2-type sporadic CJD and variant CJD, with some mice lacking any sign of transmission; and totally resistant to VV2 type sporadic CJD and dCJD with amyloid plaque. The rather short incubation time achieved by Ki-ChM mice suggests new approaches to produce mice that develop prion disease with very short incubation periods. We compared the characteristic susceptibility profile of Ki-ChM with those of other precedent transgenic mice and discussed, including the prospects in developing genetically engineered mice susceptible to human prions.
Insights
A new knock-in mouse model (Ki-ChM) shows varied susceptibility to human prions, offering a valuable tool for prion disease research and diagnostics. This model aids in understanding prion transmission and developing faster diagnostic methods.
Area of Science:
- Neuroscience
- Prion Biology
- Genetics
Background:
- Human prion diseases, such as Creutzfeldt-Jakob disease (CJD), pose significant research and diagnostic challenges.
- Developing animal models that efficiently mimic human prion diseases is crucial for understanding pathogenesis and developing therapies.
- Previous transgenic mouse models have shown limitations in susceptibility to diverse human prion strains.
Purpose of the Study:
- To evaluate the susceptibility profile of a novel knock-in mouse model (Ki-ChM) expressing a human-mouse chimeric prion protein (PrP) to various human prion strains.
- To assess the utility of the Ki-ChM mouse as a research and diagnostic tool for human prion diseases.
- To compare the Ki-ChM mouse's susceptibility with existing transgenic models.
Main Methods:
- Generation of a knock-in mouse line (Ki-ChM) expressing a chimeric human-mouse PrP.
- Intracerebral inoculation of various human prion strains, including sporadic CJD (MM1, MV1, MM2, VV2), familial CJD (M232R), variant CJD, and dura graft-associated CJD (dCJD) with and without amyloid plaques.
- Monitoring of disease onset, incubation periods, and clinical signs in inoculated mice.
- Comparison of susceptibility profiles across different prion types and with other transgenic models.
Main Results:
- The Ki-ChM mice exhibited differential susceptibility to human prions.
- High susceptibility was observed for MM1 and MV1 sporadic CJD, familial CJD (M232R), and dCJD without amyloid plaques, with short incubation periods (approx. 150 days).
- Lower susceptibility was noted for MM2 sporadic CJD and variant CJD, with some mice showing no transmission.
- Complete resistance was observed against VV2 sporadic CJD and dCJD with amyloid plaques.
Conclusions:
- The Ki-ChM mouse model demonstrates a distinct susceptibility profile to human prions, making it a valuable tool for prion disease research.
- The model's ability to develop disease within a relatively short incubation period offers new avenues for developing rapid diagnostic tools.
- Further development of genetically engineered mice, like the Ki-ChM model, holds promise for advancing our understanding and management of human prion diseases.
More Related Videos
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
In-vitro Mutagenesis (Gene Knockouts)

